White Sutton syndrome
|
0.630 |
Biomarker
|
disease |
BEFREE |
Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).
|
31782611 |
2020 |
White Sutton syndrome
|
0.630 |
AlteredExpression
|
disease |
BEFREE |
POGZ (# 614787) encodes a multidomain nuclear protein involved in transcriptional regulation and its defective function has been recently associated with a syndromic neurodevelopmental disorder, known as White-Sutton syndrome (# 616364).
|
31136090 |
2019 |
White Sutton syndrome
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
POGZ truncating alleles cause syndromic intellectual disability.
|
26739615 |
2016 |
White Sutton syndrome
|
0.630 |
AlteredExpression
|
disease |
BEFREE |
Eight of these changes affect KMT2D, ZEB2, MAP2K2, GLDC, CASK, MECP2, KDM5C, and POGZ, known to be associated with Kabuki syndrome 1, Mowat-Wilson syndrome, cardiofaciocutaneous syndrome, glycine encephalopathy, mental retardation and microcephaly with pontine and cerebellar hypoplasia, X-linked mental retardation 13, X-linked mental retardation Claes-Jensen type, and White-Sutton syndrome, respectively.
|
27799067 |
2016 |
White Sutton syndrome
|
0.630 |
CausalMutation
|
disease |
CLINVAR |
POGZ truncating alleles cause syndromic intellectual disability.
|
26739615 |
2016 |
White Sutton syndrome
|
0.630 |
CausalMutation
|
disease |
CLINVAR |
Large-scale discovery of novel genetic causes of developmental disorders.
|
25533962 |
2015 |
White Sutton syndrome
|
0.630 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
White Sutton syndrome
|
0.630 |
Biomarker
|
disease |
CTD_human |
|
|
|
Intellectual Disability
|
0.450 |
Biomarker
|
group |
BEFREE |
Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).
|
31782611 |
2020 |
Intellectual Disability
|
0.450 |
GeneticVariation
|
group |
BEFREE |
De novo likely gene-disrupting variants of POGZ cause autism spectrum disorder (ASD) and intellectual disability.
|
31347273 |
2019 |
Intellectual Disability
|
0.450 |
GeneticVariation
|
group |
BEFREE |
De novo mutations in POGZ has been causally linked to isolated ASD and syndromic ID, only recently.
|
28480548 |
2017 |
Intellectual Disability
|
0.450 |
GeneticVariation
|
group |
BEFREE |
We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ by diagnostic whole-exome, whole-genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID.
|
26942287 |
2016 |
Intellectual Disability
|
0.450 |
GeneticVariation
|
group |
BEFREE |
Our finding broadens the spectrum of POGZ mutations and may help to understand the molecular basis of ID and aid genetic counseling.
|
26763879 |
2016 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Large-scale discovery of novel genetic causes of developmental disorders.
|
25533962 |
2015 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
HPO |
|
|
|
Neurodevelopmental Disorders
|
0.340 |
GeneticVariation
|
group |
BEFREE |
Furthermore, by leveraging published large-scale sequencing data of neurodevelopmental disorders (NDDs) and sporadic case reports, we identified 8 de novo missense variants of POGZ in NDD patients.
|
31196716 |
2019 |
Neurodevelopmental Disorders
|
0.340 |
Biomarker
|
group |
BEFREE |
On the other hand, accumulating pieces of evidence indicate that the POGZ gene abnormalities are involved in various neurodevelopmental disorders.
|
31430754 |
2019 |
Neurodevelopmental Disorders
|
0.340 |
AlteredExpression
|
group |
BEFREE |
POGZ (# 614787) encodes a multidomain nuclear protein involved in transcriptional regulation and its defective function has been recently associated with a syndromic neurodevelopmental disorder, known as White-Sutton syndrome (# 616364).
|
31136090 |
2019 |
Neurodevelopmental Disorders
|
0.340 |
Biomarker
|
group |
CTD_human |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
|
28191889 |
2017 |
Neurodevelopmental Disorders
|
0.340 |
GeneticVariation
|
group |
BEFREE |
We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ by diagnostic whole-exome, whole-genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID.
|
26942287 |
2016 |
Autism Spectrum Disorders
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
We detected a novel de novo missense variant in POGZ (c.1534C>A, p.H512N, NM_015100.4) in an individual with ASD.
|
31347273 |
2019 |
Autism Spectrum Disorders
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
Our study showed the important roles of rare inherited missense variants of POGZ in ASD risk and neuronal development and identified the potential downstream targets of POGZ, which are important for further molecular mechanism studies.
|
31196716 |
2019 |
Autism Spectrum Disorders
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
De novo mutations in POGZ has been causally linked to isolated ASD and syndromic ID, only recently.
|
28480548 |
2017 |
Autism Spectrum Disorders
|
0.150 |
Biomarker
|
disease |
BEFREE |
POGZ, the gene encoding pogo transposable element-derived protein with zinc-finger domain, has been implicated in autism spectrum disorder and it is widely expressed in the human tissues, including the brain.
|
26763879 |
2016 |
Autism Spectrum Disorders
|
0.150 |
GeneticVariation
|
disease |
BEFREE |
We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ by diagnostic whole-exome, whole-genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID.
|
26942287 |
2016 |